Literature DB >> 20013308

Variable selection in the accelerated failure time model via the bridge method.

Jian Huang1, Shuangge Ma.   

Abstract

In high throughput genomic studies, an important goal is to identify a small number of genomic markers that are associated with development and progression of diseases. A representative example is microarray prognostic studies, where the goal is to identify genes whose expressions are associated with disease free or overall survival. Because of the high dimensionality of gene expression data, standard survival analysis techniques cannot be directly applied. In addition, among the thousands of genes surveyed, only a subset are disease-associated. Gene selection is needed along with estimation. In this article, we model the relationship between gene expressions and survival using the accelerated failure time (AFT) models. We use the bridge penalization for regularized estimation and gene selection. An efficient iterative computational algorithm is proposed. Tuning parameters are selected using V-fold cross validation. We use a resampling method to evaluate the prediction performance of bridge estimator and the relative stability of identified genes. We show that the proposed bridge estimator is selection consistent under appropriate conditions. Analysis of two lymphoma prognostic studies suggests that the bridge estimator can identify a small number of genes and can have better prediction performance than the Lasso.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20013308      PMCID: PMC2989175          DOI: 10.1007/s10985-009-9144-2

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  10 in total

1.  The accelerated failure time model: a useful alternative to the Cox regression model in survival analysis.

Authors:  L J Wei
Journal:  Stat Med       Date:  1992 Oct-Nov       Impact factor: 2.373

2.  Penalized Cox regression analysis in the high-dimensional and low-sample size settings, with applications to microarray gene expression data.

Authors:  Jiang Gui; Hongzhe Li
Journal:  Bioinformatics       Date:  2005-04-06       Impact factor: 6.937

3.  Regularized estimation in the accelerated failure time model with high-dimensional covariates.

Authors:  Jian Huang; Shuangge Ma; Huiliang Xie
Journal:  Biometrics       Date:  2006-09       Impact factor: 2.571

4.  Doubly penalized buckley-james method for survival data with high-dimensional covariates.

Authors:  Sijian Wang; Bin Nan; Ji Zhu; David G Beer
Journal:  Biometrics       Date:  2007-08-03       Impact factor: 2.571

5.  The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma.

Authors:  Andreas Rosenwald; George Wright; Adrian Wiestner; Wing C Chan; Joseph M Connors; Elias Campo; Randy D Gascoyne; Thomas M Grogan; H Konrad Muller-Hermelink; Erlend B Smeland; Michael Chiorazzi; Jena M Giltnane; Elaine M Hurt; Hong Zhao; Lauren Averett; Sarah Henrickson; Liming Yang; John Powell; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Richard D Klausner; Emilio Montserrat; Francesc Bosch; Timothy C Greiner; Dennis D Weisenburger; Warren G Sanger; Bhavana J Dave; James C Lynch; Julie Vose; James O Armitage; Richard I Fisher; Thomas P Miller; Michael LeBlanc; German Ott; Stein Kvaloy; Harald Holte; Jan Delabie; Louis M Staudt
Journal:  Cancer Cell       Date:  2003-02       Impact factor: 31.743

6.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.

Authors:  A A Alizadeh; M B Eisen; R E Davis; C Ma; I S Lossos; A Rosenwald; J C Boldrick; H Sabet; T Tran; X Yu; J I Powell; L Yang; G E Marti; T Moore; J Hudson; L Lu; D B Lewis; R Tibshirani; G Sherlock; W C Chan; T C Greiner; D D Weisenburger; J O Armitage; R Warnke; R Levy; W Wilson; M R Grever; J C Byrd; D Botstein; P O Brown; L M Staudt
Journal:  Nature       Date:  2000-02-03       Impact factor: 49.962

7.  The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

Authors:  Andreas Rosenwald; George Wright; Wing C Chan; Joseph M Connors; Elias Campo; Richard I Fisher; Randy D Gascoyne; H Konrad Muller-Hermelink; Erlend B Smeland; Jena M Giltnane; Elaine M Hurt; Hong Zhao; Lauren Averett; Liming Yang; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Richard D Klausner; John Powell; Patricia L Duffey; Dan L Longo; Timothy C Greiner; Dennis D Weisenburger; Warren G Sanger; Bhavana J Dave; James C Lynch; Julie Vose; James O Armitage; Emilio Montserrat; Armando López-Guillermo; Thomas M Grogan; Thomas P Miller; Michel LeBlanc; German Ott; Stein Kvaloy; Jan Delabie; Harald Holte; Peter Krajci; Trond Stokke; Louis M Staudt
Journal:  N Engl J Med       Date:  2002-06-20       Impact factor: 91.245

8.  Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.

Authors:  Sandeep S Dave; George Wright; Bruce Tan; Andreas Rosenwald; Randy D Gascoyne; Wing C Chan; Richard I Fisher; Rita M Braziel; Lisa M Rimsza; Thomas M Grogan; Thomas P Miller; Michael LeBlanc; Timothy C Greiner; Dennis D Weisenburger; James C Lynch; Julie Vose; James O Armitage; Erlend B Smeland; Stein Kvaloy; Harald Holte; Jan Delabie; Joseph M Connors; Peter M Lansdorp; Qin Ouyang; T Andrew Lister; Andrew J Davies; Andrew J Norton; H Konrad Muller-Hermelink; German Ott; Elias Campo; Emilio Montserrat; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Liming Yang; John Powell; Hong Zhao; Neta Goldschmidt; Michael Chiorazzi; Louis M Staudt
Journal:  N Engl J Med       Date:  2004-11-18       Impact factor: 91.245

9.  A group bridge approach for variable selection.

Authors:  Jian Huang; Shuange Ma; Huiliang Xie; Cun-Hui Zhang
Journal:  Biometrika       Date:  2009-06       Impact factor: 2.445

10.  Additive risk survival model with microarray data.

Authors:  Shuangge Ma; Jian Huang
Journal:  BMC Bioinformatics       Date:  2007-06-08       Impact factor: 3.169

  10 in total
  29 in total

1.  Identification of Breast Cancer Prognosis Markers via Integrative Analysis.

Authors:  Shuangge Ma; Ying Dai; Jian Huang; Yang Xie
Journal:  Comput Stat Data Anal       Date:  2012-09-01       Impact factor: 1.681

2.  Low-dimensional confounder adjustment and high-dimensional penalized estimation for survival analysis.

Authors:  Xiaochao Xia; Binyan Jiang; Jialiang Li; Wenyang Zhang
Journal:  Lifetime Data Anal       Date:  2015-10-13       Impact factor: 1.588

3.  Robust network-based regularization and variable selection for high-dimensional genomic data in cancer prognosis.

Authors:  Jie Ren; Yinhao Du; Shaoyu Li; Shuangge Ma; Yu Jiang; Cen Wu
Journal:  Genet Epidemiol       Date:  2019-02-11       Impact factor: 2.135

4.  Analyzing Association Mapping in Pedigree-Based GWAS Using a Penalized Multitrait Mixed Model.

Authors:  Jin Liu; Can Yang; Xingjie Shi; Cong Li; Jian Huang; Hongyu Zhao; Shuangge Ma
Journal:  Genet Epidemiol       Date:  2016-06-01       Impact factor: 2.135

5.  Integrative analysis of prognosis data on multiple cancer subtypes.

Authors:  Jin Liu; Jian Huang; Yawei Zhang; Qing Lan; Nathaniel Rothman; Tongzhang Zheng; Shuangge Ma
Journal:  Biometrics       Date:  2014-04-25       Impact factor: 2.571

6.  Assisted gene expression-based clustering with AWNCut.

Authors:  Yang Li; Ruofan Bie; Sebastian J Teran Hidalgo; Yichen Qin; Mengyun Wu; Shuangge Ma
Journal:  Stat Med       Date:  2018-08-09       Impact factor: 2.373

7.  Integrative analysis of gene-environment interactions under a multi-response partially linear varying coefficient model.

Authors:  Cen Wu; Yuehua Cui; Shuangge Ma
Journal:  Stat Med       Date:  2014-08-21       Impact factor: 2.373

8.  Integrative analysis of multiple cancer prognosis studies with gene expression measurements.

Authors:  Shuangge Ma; Jian Huang; Fengrong Wei; Yang Xie; Kuangnan Fang
Journal:  Stat Med       Date:  2011-08-25       Impact factor: 2.373

9.  Integrative sparse principal component analysis of gene expression data.

Authors:  Mengque Liu; Xinyan Fan; Kuangnan Fang; Qingzhao Zhang; Shuangge Ma
Journal:  Genet Epidemiol       Date:  2017-11-08       Impact factor: 2.135

10.  Integrative Analysis of Cancer Diagnosis Studies with Composite Penalization.

Authors:  Jin Liu; Jian Huang; Shuangge Ma
Journal:  Scand Stat Theory Appl       Date:  2014-03-01       Impact factor: 1.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.